Variant report
Variant | esv1814514 |
---|---|
Chromosome Location | chr5:114255927-114261056 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs544342130 | chr5:114260602-114260603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs4346763 | chr5:114260619-114260620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs578000925 | chr5:114260632-114260633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs545409102 | chr5:114260634-114260635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs185840230 | chr5:114260635-114260636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs151275488 | chr5:114260637-114260638 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs541515335 | chr5:114260650-114260651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs561103236 | chr5:114260658-114260659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs554658920 | chr5:114260668-114260669 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs531542654 | chr5:114260683-114260684 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs549661650 | chr5:114260685-114260686 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs139238652 | chr5:114260753-114260754 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs538319213 | chr5:114260754-114260755 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs149987638 | chr5:114260758-114260759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs189153301 | chr5:114260763-114260764 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs534268834 | chr5:114260794-114260795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs530050510 | chr5:114260833-114260834 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs146554892 | chr5:114260860-114260861 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs538054043 | chr5:114260867-114260868 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs141423187 | chr5:114260887-114260888 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs578062582 | chr5:114260905-114260906 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs115370018 | chr5:114260939-114260940 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs73782620 | chr5:114260943-114260944 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Sezary syndrome | 18413736 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:114260600-114260800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr5:114260600-114261000 | Enhancers | Fetal Brain Male | brain |
3 | chr5:114260800-114264400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |